Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 731-739, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Tito, B. J.
Right arrow Articles by Bailey, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Tito, B. J., Jr.
Right arrow Articles by Bailey, A. L.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 1998;44:731-739.)
© 1998 American Association for Clinical Chemistry, Inc.

Molecular Pathology and Genetics

Automated fluorescent analysis procedure for enzymatic mutation detection

Benjamin J. Del Tito, Jr.1,2,1, Herbert E. Poff, III1,2, Mark A. Novotny1,2, Donna M. Cartledge1,2, Ralph I. Walker, II1,2, Christopher D. Earl1, and Anne L. Bailey1,2,a

1 Avitech Diagnostics, Inc., 30 Spring Mill Drive, Malvern, PA 19355.

2 Variagenics, Inc., One Kendall Square, Cambridge, MA 02139.
a Address correspondence to this author at: North American Vaccine, Inc., 12103 Indian Creek Court, Beltsville, MD 20705.

The Enzymatic Mutation Detection(TM) (EMD) assay detects mutations or polymorphisms in DNA. The assay procedure takes <1 h and is followed by electrophoretic detection. We report an automated procedure, using fluorescently labeled probe and quantitative analysis on the ABI Prism(TM) 377 DNA Sequencer, that improves on earlier methods (1, 2) by eliminating the need for sample purification, shortening the hybridization time, and increasing the signal-to-noise ratio. The EMD assay uses the bacteriophage resolvase T4 endonuclease VII, which cleaves the heteroduplex molecules at the mismatch site, forming two shorter fragments that are resolved by gel electrophoresis. Unlike existing mutation techniques, the EMD method uses a single protocol to identify point mutations, deletions, and insertions for all DNA fragments. Test DNA samples are assayed directly from PCR reactions, and fragments up to 4 kb in size have been assayed successfully. A independent analysis on the p53 tumor suppressor gene from clinical samples has shown 100% sensitivity and 94% specificity. Because the fluorescent EMD assay has been optimized for high signal-to-noise ratios, mutations can be identified in mixed samples containing up to a 20-fold excess of normal DNA.




The following articles in journals at HighWire Press have cited this article:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. W. Haile, D. C. Thomas, V. McGuire, A. Felberg, E. M. John, R. L. Milne, J. L. Hopper, M. A. Jenkins, A. J. Levine, M. M. Daly, et al.
BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1863 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 J Exp BotHome page
C-A Whittle and M. Johnston
Moving forward in determining the causes of mutations: the features of plants that make them suitable for assessing the impact of environmental factors and cell age
J. Exp. Bot., June 1, 2006; 57(9): 1847 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. J. Smith, G. Pante-de-Sousa, K. K. Alharbi, X.-h. Chen, I. N.M. Day, and K. R. Fox
Combination of His-Tagged T4 Endonuclease VII with Microplate Array Diagonal Gel Electrophoresis for High-Throughput Mutation Scanning
Clin. Chem., June 1, 2005; 51(6): 1043 - 1046.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
Y. Li, I. Marcos, S. Borrego, Z. Yu, K. Zhang, and G. Antinolo
Evaluation of the ELOVL4 gene in families with retinitis pigmentosa linked to the RP25 locus
J. Med. Genet., July 1, 2001; 38(7): 478 - 480.
[Full Text]

Home page
 Clin. Chem.Home page
T. Norberg, S. Klaar, L. Lindqvist, T. Lindahl, J. Ahlgren, and J. Bergh
Enzymatic Mutation Detection Method Evaluated for Detection of p53 Mutations in cDNA from Breast Cancers
Clin. Chem., May 1, 2001; 47(5): 821 - 828.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Inganas, S. Byding, A. Eckersten, S. Eriksson, T. Hultman, A. Jorsback, E. Lofman, F. Sabounchi, U. Kressner, G. Lindmark, et al.
Enzymatic Mutation Detection in the P53 Gene
Clin. Chem., October 1, 2000; 46(10): 1562 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. Schmalzing, A. Belenky, M. A. Novotny, L. Koutny, O. Salas-Solano, S. El-Difrawy, A. Adourian, P. Matsudaira, and D. Ehrlich
Microchip electrophoresis: a method for high-speed SNP detection
Nucleic Acids Res., May 1, 2000; 28(9): e43 - e43.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
Z. Guo, M. S. Gatterman, L. Hood, J. A. Hansen, and E. W. Petersdorf
Oligonucleotide Arrays for High-Throughput SNPs Detection in the MHC Class I Genes: HLA-B as a Model System
Genome Res., March 1, 2002; 12(3): 447 - 457.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.